カテゴリー： 世界, 医療/バイオ, Grand View Research

世界の血友病市場2023-2030：種類別（血友病A）、治療種類別（オンデマンド）、治療法別（遺伝子治療、モノクローナル抗体）、流通チャネル別、地域別

【英語タイトル】Hemophilia Market Size, Share & Trends Analysis Report By Type (Hemophilia A), By Treatment Type (On-demand), By Therapy (Gene Therapy & Monoclonal Antibodies), By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料（GRV23AUG060）・商品コード：GRV23AUG060
・発行会社（調査会社）：Grand View Research
・発行日：2023年7月25日
・ページ数：105
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,360,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

血友病市場の成長と動向
Grand View Research, Inc.の最新レポートによると、世界の血友病市場規模は2023年から2030年にかけて年平均成長率6.6%で拡大し、2030年には210億7000万米ドルに達する見込みです。血友病治療のための遺伝子治療やモノクローナル抗体が承認され、パイプラインにそのような候補が複数存在することが市場成長の主な促進要因となっています。さらに、死亡率の低下による血友病患者の平均余命の延長も市場成長を促進する主要因です。

血友病をコントロールする新規治療薬の開発と上市が市場成長を後押ししています。例えば、2020年4月、FDAは、青少年（12歳以上の年齢層）および成人における出血エピソードを制御する治療オプションとして、遺伝子操作製品Sevenfact [凝固第VIIa因子（遺伝子組換え）-jncw]を承認しました。さらに、バイオマリン社の血友病A治療薬Roctavianは欧州でのみ承認されており、CSL社のHemgenix（etranacogene dezaparvovec-drib）は米国と欧州の両方で承認されていることから、2つの遺伝子治療製品が存在することは、他地域での拡大の機会を示しています。バイオマリンのRoctavianは、前回却下された後、米国FDAで審査中であり、PDUFA期日は2023年6月30日に設定されています。

大手企業は、新製品の開発や戦略的提携に注力し、地理的プレゼンスを高めています。例えば、2022年4月、ノボ・ノルディスクA/Sはカナディアン・ブラッド・サービスと提携し、A型治療薬として市販されているエスペロクトとゾノベートの製品ラインナップを強化しました。

しかし、中国やインドなどの発展途上国では、軽症から中等症の診断が遅れていることが主な阻害要因となっています。市場にとってのもう一つの重要な課題は、高コストと長期データの不足により、遺伝子治療へのアクセスに問題が生じる可能性があることです。例えば、ヘムジェニックス（2022年承認）による治療費は1回あたり350万米ドルで、世界で最も高額な治療法となっています。

血友病市場レポートハイライト

- 血友病Aは有病率が高く、複数の治療薬が存在することから、A型セグメントが血友病市場で最大のシェアを占めています。また、遺伝子治療が承認されたことにより、予測期間中、このセグメントは最も高いCAGRで成長する見込みです。

- 販売チャネル別では、専門薬局が2022年に最大の市場シェアを占めました。

- 治療法別では、因子補充療法が2022年に血友病市場で最大のシェアを獲得しました。

- 北米は2022年の血友病市場において最大の収益を生み出す地域であり、これは主要プレイヤーの存在、規制当局のサポート、患者の意識、有利な資金援助に起因しています。

第1章. 調査方法
第2章. 市場の定義
第3章. エグゼクティブサマリー
第4章. 血友病市場変動・動向・範囲
第5章. 血友病市場：タイプ別分析、2018年～2030年（百万ドル）
第6章. 血友病市場：治療タイプ別分析、2018年～2030年（百万ドル）
第7章. 血友病市場：治療法別分析、2018年～2030年（百万ドル）
第8章. 血友病市場：流通チャネル別分析、2018年～2030年（百万ドル）
第9章. 血友病市場：地域別分析、2018年～2030年（百万ドル）
第10章. 競争状況

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Table of Contents

Chapter 1 Research Methodology
1.1 Market Segmentation & Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.1.2 Approach 2: Country-Wise Market Estimation Using Bottom-Up Approach
1.7 Global Market: Cagr Calculation
1.8 Research Assumptions
1.9 List Of Secondary Sources
1.10 List Of Primary Sources
1.11 Objectives
1.11.1 Objective 1:
1.11.2 Objective 2:
1.12 List Of Abbreviations
Chapter 2 Market Definitions
Chapter 3 Executive Summary
3.1 Market Summary
Chapter 4 Hemophilia Market Variables, Trends, & Scope
4.1 Hemophilia Market Lineage Outlook
4.1.1 Parent Market Outlook
4.2 Penetration And Growth Prospect Mapping
4.3 Market Driver Analysis
4.3.1 Increasing Population Of Newborns
4.3.2 Favorable Government Initiatives
4.3.3 Rising R&D And New Product Development
4.3.4 Rising Adoption Of Prophylaxis Treatment
4.4 Market Restraint Analysis
4.4.1 High Cost Associated With Procuring Treatment
4.5 Porter’s Five Forces Analysis
4.6 Pestle Analysis
4.7 Pipeline Analysis
Chapter 5 Hemophilia Market – Segment Analysis, By Type, 2018 – 2030 (USD Million)
5.1 Global Hemophilia Market: Type Movement Analysis
5.2. Hemophilia A5.2.1. Hemophilia A Market Estimates And Forecasts, 2018 – 2030 (USD Million)
5.3. Hemophilia B
5.3.1. Hemophilia B Market Estimates And Forecasts, 2018 – 2030 (USD Million)
5.4. Others
5.4.1 Others Market Estimates And Forecasts, 2018 – 2030 (USD Million)
Chapter 6 Hemophilia Market- Segment Analysis, By Treatment Type, 2018 – 2030 (USD Million)
6.1 Global Hemophilia Market: Treatment Type Movement Analysis
6.2. Prophylaxis
6.2.1. Prophylaxis Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.3. On-Demand
6.3.1. On-Demand Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.4. Cure
6.4.1. Cure Market Estimates And Forecasts, 2018 – 2030 (USD Million)
Chapter 7 Hemophilia Market – Segment Analysis, By Therapy, 2018 – 2030 (USD Million)
7.1 Global Hemophilia Market: Therapy Movement Analysis
7.2. Factor Replacement Therapy
7.2.1. Factor Replacement Therapy Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.2.1.1 Plasma Derived Factor Concentrates
7.2.1.1.1 Plasma Derived Factor Concentrates Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.2.1.1.2 Factor Viii Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.2.1.1.3 Factor Ix Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.2.1.2 Recombinant Factor Concentrates
7.2.1.2.1 Recombinant Factor Concentrates Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.2.1.2.2 Factor Viii Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.2.1.2.3 Factor Vii Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.2.1.2.4 Factor Vii Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.3. Gene Therapy & Monoclonal Antibodies
7.3.1. Gene Therapy & Monoclonal Antibodies Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.4. Desmopressin & Fibrin Sealants
7.4.1 Desmopressin & Fibrin Sealants Market Estimates And Forecasts, 2018 – 2030 (USD Million)
Chapter 8 Hemophilia Market – Segment Analysis, By Distribution Channel, 2018 – 2030 (USD Million)
8.1 Global Hemophilia Market: Distribution Channel Movement Analysis
8.2. Hospital Pharmacies
8.2.1. Hospital Pharmacies Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.3. Specialty Pharmacies
8.3.1. Specialty Pharmacies Market Estimates And Forecasts, 2018 – 2030 (USD Million)
Chapter 9 Hemophilia Market: – Segment Analysis, by Region, 2018 – 2030 (USD Million)
9.1 Hemophilia Market: Regional Outlook
9.2 North America
9.2.1 North America Hemophilia Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.2.2 U.S.
9.2.2.1 Key Country Dynamics
9.2.2.2 U.S. Hemophilia Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million)
9.2.2.3 Target Disease Prevalence
9.2.2.4 Competitive Scenario
9.2.2.5 Regulatory Framework
9.2.2.6 Reimbursement Scenario
9.2.3 Canada
9.2.3.1 Key Country Dynamics
9.2.3.2 Canada Hemophilia Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million)
9.2.3.3 Target Disease Prevalence
9.2.3.4 Competitive Scenario
9.2.3.5 Regulatory Framework
9.2.3.6 Reimbursement Scenario
9.3 Europe
9.3.1 Europe Hemophilia Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.3.2 UK
9.3.2.1 Key Country Dynamics
9.3.2.2 UK Hemophilia Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million)
9.3.2.3 Target Disease Prevalence
9.3.2.4 Competitive Scenario
9.3.2.5 Regulatory Framework
9.3.2.6 Reimbursement Scenario
9.3.3 Germany
9.3.3.1 Key Country Dynamics
9.3.3.2 Germany Hemophilia Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million)
9.3.3.3 Target Disease Prevalence
9.3.3.4 Competitive Scenario
9.3.3.5 Regulatory Framework
9.3.3.6 Reimbursement Scenario
9.3.4 France
9.3.4.1 Key Country Dynamics
9.3.4.2 France Hemophilia Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million)
9.3.4.3 Target Disease Prevalence
9.3.4.4 Competitive Scenario
9.3.4.5 Regulatory Framework
9.3.4.6 Reimbursement Scenario
9.3.5 Italy
9.3.5.1 Key Country Dynamics
9.3.5.2 Italy Hemophilia Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million)
9.3.5.3 Target Disease Prevalence
9.3.5.4 Competitive Scenario
9.3.5.5 Regulatory Framework
9.3.5.6 Reimbursement Scenario
9.3.6 Spain
9.3.6.1 Key Country Dynamics
9.3.6.2 Spain Hemophilia Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million)
9.3.6.3 Target Disease Prevalence
9.3.6.4 Competitive Scenario
9.3.6.5 Regulatory Framework
9.3.6.6 Reimbursement Scenario
9.3.7 Denmark
9.3.7.1 Key Country Dynamics
9.3.7.2 Denmark Hemophilia Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million)
9.3.7.3 Target Disease Prevalence
9.3.7.4 Competitive Scenario
9.3.7.5 Regulatory Framework
9.3.7.6 Reimbursement Scenario
9.3.8 Sweden
9.3.8.1 Key Country Dynamics
9.3.8.2 Sweden Hemophilia Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million)
9.3.8.3 Target Disease Prevalence
9.3.8.4 Competitive Scenario
9.3.8.5 Regulatory Framework
9.3.8.6 Reimbursement Scenario
9.3.9 Norway
9.3.9.1 Key Country Dynamics
9.3.9.2 Norway Hemophilia Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million)
9.3.9.3 Target Disease Prevalence
9.3.9.4 Competitive Scenario
9.3.9.5 Regulatory Framework
9.3.9.6 Reimbursement Scenario
9.4 Asia Pacific
9.4.1 Asia Pacific Hemophilia Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.4.2 Japan
9.4.2.1 Key Country Dynamics
9.4.2.2 Japan Hemophilia Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million)
9.4.2.3 Target Disease Prevalence
9.4.2.4 Competitive Scenario
9.4.2.5 Regulatory Framework
9.4.2.6 Reimbursement Scenario
9.4.3 China
9.4.3.1 Key Country Dynamics
9.4.3.2 China Hemophilia Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million)
9.4.3.3 Target Disease Prevalence
9.4.3.4 Competitive Scenario
9.4.3.5 Regulatory Framework
9.4.3.6 Reimbursement Scenario
9.4.4 India
9.4.4.1 Key Country Dynamics
9.4.4.2 India Hemophilia Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million)
9.4.4.3 Target Disease Prevalence
9.4.4.4 Competitive Scenario
9.4.4.5 Regulatory Framework
9.4.4.6 Reimbursement Scenario
9.4.5 Australia
9.4.5.1 Key Country Dynamics
9.4.5.2 Australia Hemophilia Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million)
9.4.5.3 Target Disease Prevalence
9.4.5.4 Competitive Scenario
9.4.5.5 Regulatory Framework
9.4.5.6 Reimbursement Scenario
9.4.6 South Korea
9.4.6.1 Key Country Dynamics
9.4.6.2 South Korea Hemophilia Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million)
9.4.6.3 Target Disease Prevalence
9.4.6.4 Competitive Scenario
9.4.6.5 Regulatory Framework
9.4.6.6 Reimbursement Scenario
9.4.7 Thailand
9.4.7.1 Key Country Dynamics
9.4.7.2 Thailand Hemophilia Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million)
9.4.7.3 Target Disease Prevalence
9.4.7.4 Competitive Scenario
9.4.7.5 Regulatory Framework
9.4.7.6 Reimbursement Scenario
9.5 Latin America
9.5.1 Latin America Hemophilia Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.5.2 Brazil
9.5.2.1 Key Country Dynamics
9.5.2.2 Brazil Hemophilia Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million)
9.5.2.3 Target Disease Prevalence
9.5.2.4 Competitive Scenario
9.5.2.5 Regulatory Framework
9.5.2.6 Reimbursement Scenario
9.5.3 Mexico
9.5.3.1 Key Country Dynamics
9.5.3.2 Mexico Hemophilia Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million)
9.5.3.3 Target Disease Prevalence
9.5.3.4 Competitive Scenario
9.5.3.5 Regulatory Framework
9.5.3.6 Reimbursement Scenario
9.5.4 Argentina
9.5.4.1 Key Country Dynamics
9.5.4.2 Argentina Hemophilia Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million)
9.5.4.3 Target Disease Prevalence
9.5.4.4 Competitive Scenario
9.5.4.5 Regulatory Framework
9.5.4.6 Reimbursement Scenario
9.6 Middle East and Africa
9.6.1 Middle East and Africa Hemophilia Market Estimates And Forecasts, 2018 – 2030 (USD Million)
9.6.1.1 Target Disease Prevalence
9.6.1.2 Competitive Scenario
9.6.1.3 Regulatory Framework
9.6.1.4 Reimbursement Scenario
9.6.2 South Africa
9.6.2.1 Key Country Dynamics
9.6.2.2 South Africa Hemophilia Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million)
9.6.2.3 Target Disease Prevalence
9.6.2.4 Competitive Scenario
9.6.2.5 Regulatory Framework
9.6.2.6 Reimbursement Scenario
9.6.3 Saudi Arabia
9.6.3.1 Key Country Dynamics
9.6.3.2 Saudi Arabia Hemophilia Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million)
9.6.3.3 Target Disease Prevalence
9.6.3.4 Competitive Scenario
9.6.3.5 Regulatory Framework
9.6.3.6 Reimbursement Scenario
9.6.4 UAE
9.6.4.1 Key Country Dynamics
9.6.4.2 UAE Hemophilia Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million)
9.6.4.3 Target Disease Prevalence
9.6.4.4 Competitive Scenario
9.6.4.5 Regulatory Framework
9.6.4.6 Reimbursement Scenario
9.6.5 KUWAIT
9.6.5.1 Key Country Dynamics
9.6.5.2 Kuwait Hemophilia Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million)
9.6.5.3 Target Disease Prevalence
9.6.5.4 Competitive Scenario
9.6.5.5 Regulatory Framework
9.6.5.6 Reimbursement Scenario
Chapter 10 Competitive Landscape
10.1 Company Categorization
10.2 Participant’s Overview
10.3 Financial Performance
10.4 Product Benchmarking
10.5 Company Market Positioning
10.6 Company Market Share Analysis, 2022
10.7 Company Heat Map Analysis
10.8 Strategic Initiatives
10.9 Company Profiles
10.9.1 NOVO NORDISK A/S
10.9.2 TAKEDA PHARMACEUTICAL COMPANY LIMITED
10.9.3 F. HOFFMANN LA-ROCHE LTD.
10.9.4 BAYER AG
10.9.5 PFIZER, INC.
10.9.6 CSL BEHRING
10.9.7 BIOMARIN
10.9.8 OCTOPHARMA AG
10.9.9 SANOFI
10.9.10 SPARK THERAPEUTICS, INC.

List of Tables

TABLE 1 List of Abbreviation
TABLE 2 Global Hemophilia Market, By Region, 2018 - 2030 (USD Million)
TABLE 3 North America Hemophilia Market, By Country, 2018 - 2030 (USD Million)
TABLE 4 North America Hemophilia Market, By Type, 2018 - 2030 (USD Million)
TABLE 5 North America Hemophilia Market, By Treatment Type, 2018 - 2030 (USD Million)
TABLE 6 North America Hemophilia Market, By Therapy, 2018 - 2030 (USD Million)
TABLE 7 North America Hemophilia Market, By Distribution Channel, 2018 - 2030 (USD Million)
TABLE 8 U.S. Hemophilia Market, By Type, 2018 - 2030 (USD Million)
TABLE 9 U.S. Hemophilia Market, By Treatment Type, 2018 - 2030 (USD Million)
TABLE 10 U.S. Hemophilia Market, By Therapy, 2018 - 2030 (USD Million)
TABLE 11 U.S. Hemophilia Market, By Distribution Channel, 2018 - 2030 (USD Million)
TABLE 12 Canada Hemophilia Market, By Type, 2018 - 2030 (USD Million)
TABLE 13 Canada Hemophilia Market, By Treatment Type, 2018 - 2030 (USD Million)
TABLE 14 Canada Hemophilia Market, By Therapy, 2018 - 2030 (USD Million)
TABLE 15 Canada Hemophilia Market, By Distribution Channel, 2018 - 2030 (USD Million)
TABLE 16 Europe Hemophilia Market, By Country, 2018 - 2030 (USD Million)
TABLE 17 Europe Hemophilia Market, By Type, 2018 - 2030 (USD Million)
TABLE 18 Europe Hemophilia Market, By Treatment Type, 2018 - 2030 (USD Million)
TABLE 19 Europe Hemophilia Market, By Therapy, 2018 - 2030 (USD Million)
TABLE 20 Europe Hemophilia Market, By Distribution Channel, 2018 - 2030 (USD Million)
TABLE 21 UK Hemophilia Market, By Type, 2018 - 2030 (USD Million)
TABLE 22 UK Hemophilia Market, By Treatment Type, 2018 - 2030 (USD Million)
TABLE 23 UK Hemophilia Market, By Therapy, 2018 - 2030 (USD Million)
TABLE 24 UK Hemophilia Market, By Distribution Channel, 2018 - 2030 (USD Million)
TABLE 25 Germany Hemophilia Market, By Type, 2018 - 2030 (USD Million)
TABLE 26 Germany Hemophilia Market, By Treatment Type, 2018 - 2030 (USD Million)
TABLE 27 Germany Hemophilia Market, By Therapy, 2018 - 2030 (USD Million)
TABLE 28 Germany Hemophilia Market, By Distribution Channel, 2018 - 2030 (USD Million)
TABLE 29 France Hemophilia Market, By Type, 2018 - 2030 (USD Million)
TABLE 30 France Hemophilia Market, By Treatment Type, 2018 - 2030 (USD Million)
TABLE 31 France Hemophilia Market, By Therapy, 2018 - 2030 (USD Million)
TABLE 32 France Hemophilia Market, By Distribution Channel, 2018 - 2030 (USD Million)
TABLE 33 Italy Hemophilia Market, By Type, 2018 - 2030 (USD Million)
TABLE 34 Italy Hemophilia Market, By Treatment Type, 2018 - 2030 (USD Million)
TABLE 35 Italy Hemophilia Market, By Therapy, 2018 - 2030 (USD Million)
TABLE 36 Italy Hemophilia Market, By Distribution Channel, 2018 - 2030 (USD Million)
TABLE 37 Spain Hemophilia Market, By Type, 2018 - 2030 (USD Million)
TABLE 38 Spain Hemophilia Market, By Treatment Type, 2018 - 2030 (USD Million)
TABLE 39 Spain Hemophilia Market, By Therapy, 2018 - 2030 (USD Million)
TABLE 40 Spain Hemophilia Market, By Distribution Channel, 2018 - 2030 (USD Million)
TABLE 41 Denmark Hemophilia Market, By Type, 2018 - 2030 (USD Million)
TABLE 42 Denmark Hemophilia Market, By Treatment Type, 2018 - 2030 (USD Million)
TABLE 43 Denmark Hemophilia Market, By Therapy, 2018 - 2030 (USD Million)
TABLE 44 Denmark Hemophilia Market, By Distribution Channel, 2018 - 2030 (USD Million)
TABLE 45 Sweden Hemophilia Market, By Type, 2018 - 2030 (USD Million)
TABLE 46 Sweden Hemophilia Market, By Treatment Type, 2018 - 2030 (USD Million)
TABLE 47 Sweden Hemophilia Market, By Therapy, 2018 - 2030 (USD Million)
TABLE 48 Sweden Hemophilia Market, By Distribution Channel, 2018 - 2030 (USD Million)
TABLE 49 Norway Hemophilia Market, By Type, 2018 - 2030 (USD Million)
TABLE 50 Norway Hemophilia Market, By Treatment Type, 2018 - 2030 (USD Million)
TABLE 51 Norway Hemophilia Market, By Therapy, 2018 - 2030 (USD Million)
TABLE 52 Norway Hemophilia Market, By Distribution Channel, 2018 - 2030 (USD Million)
TABLE 53 Asia Pacific Hemophilia Market, By Country, 2018 - 2030 (USD Million)
TABLE 54 Asia Pacific Hemophilia Market, By Type, 2018 - 2030 (USD Million)
TABLE 55 Asia Pacific Hemophilia Market, By Treatment Type, 2018 - 2030 (USD Million)
TABLE 56 Asia Pacific Hemophilia Market, By Therapy, 2018 - 2030 (USD Million)
TABLE 57 Asia Pacific Hemophilia Market, By Distribution Channel, 2018 - 2030 (USD Million)
TABLE 58 Japan Hemophilia Market, By Type, 2018 - 2030 (USD Million)
TABLE 59 Japan Hemophilia Market, By Treatment Type, 2018 - 2030 (USD Million)
TABLE 60 Japan Hemophilia Market, By Therapy, 2018 - 2030 (USD Million)
TABLE 61 Japan Hemophilia Market, By Distribution Channel, 2018 - 2030 (USD Million)
TABLE 62 China Hemophilia Market, By Type, 2018 - 2030 (USD Million)
TABLE 63 China Hemophilia Market, By Treatment Type, 2018 - 2030 (USD Million)
TABLE 64 China Hemophilia Market, By Therapy, 2018 - 2030 (USD Million)
TABLE 65 China Hemophilia Market, By Distribution Channel, 2018 - 2030 (USD Million)
TABLE 66 India Hemophilia Market, By Type, 2018 - 2030 (USD Million)
TABLE 67 India Hemophilia Market, By Treatment Type, 2018 - 2030 (USD Million)
TABLE 68 India Hemophilia Market, By Therapy, 2018 - 2030 (USD Million)
TABLE 69 India Hemophilia Market, By Distribution Channel, 2018 - 2030 (USD Million)
TABLE 70 South Korea Hemophilia Market, By Type, 2018 - 2030 (USD Million)
TABLE 71 South Korea Hemophilia Market, By Treatment Type, 2018 - 2030 (USD Million)
TABLE 72 South Korea Hemophilia Market, By Therapy, 2018 - 2030 (USD Million)
TABLE 73 South Korea Hemophilia Market, By Distribution Channel, 2018 - 2030 (USD Million)
TABLE 74 Australia Hemophilia Market, By Type, 2018 - 2030 (USD Million)
TABLE 75 Australia Hemophilia Market, By Treatment Type, 2018 - 2030 (USD Million)
TABLE 76 Australia Hemophilia Market, By Therapy, 2018 - 2030 (USD Million)
TABLE 77 Australia Hemophilia Market, By Distribution Channel, 2018 - 2030 (USD Million)
TABLE 78 Thailand Hemophilia Market, By Type, 2018 - 2030 (USD Million)
TABLE 79 Thailand Hemophilia Market, By Treatment Type, 2018 - 2030 (USD Million)
TABLE 80 Thailand Hemophilia Market, By Therapy, 2018 - 2030 (USD Million)
TABLE 81 Thailand Hemophilia Market, By Distribution Channel, 2018 - 2030 (USD Million)
TABLE 82 Latin America Hemophilia Market, By Country, 2018 - 2030 (USD Million)
TABLE 83 Latin America Hemophilia Market, By Type, 2018 - 2030 (USD Million)
TABLE 84 Latin America Hemophilia Market, By Treatment Type, 2018 - 2030 (USD Million)
TABLE 85 Latin America Hemophilia Market, By Therapy, 2018 - 2030 (USD Million)
TABLE 86 Latin America Hemophilia Market, By Distribution Channel, 2018 - 2030 (USD Million)
TABLE 87 Mexico Hemophilia Market, By Type, 2018 - 2030 (USD Million)
TABLE 88 Mexico Hemophilia Market, By Treatment Type, 2018 - 2030 (USD Million)
TABLE 89 Mexico Hemophilia Market, By Therapy, 2018 - 2030 (USD Million)
TABLE 90 Mexico Hemophilia Market, By Distribution Channel, 2018 - 2030 (USD Million)
TABLE 91 Brazil Hemophilia Market, By Type, 2018 - 2030 (USD Million)
TABLE 92 Brazil Hemophilia Market, By Treatment Type, 2018 - 2030 (USD Million)
TABLE 93 Brazil Hemophilia Market, By Therapy, 2018 - 2030 (USD Million)
TABLE 94 Brazil Hemophilia Market, By Distribution Channel, 2018 - 2030 (USD Million)
TABLE 95 Argentina Hemophilia Market, By Type, 2018 - 2030 (USD Million)
TABLE 96 Argentina Hemophilia Market, By Treatment Type, 2018 - 2030 (USD Million)
TABLE 97 Argentina Hemophilia Market, By Therapy, 2018 - 2030 (USD Million)
TABLE 98 Argentina Hemophilia Market, By Distribution Channel, 2018 - 2030 (USD Million)
TABLE 99 MEA Hemophilia Market, By Country, 2018 - 2030 (USD Million)
TABLE 100 MEA Hemophilia Market, By Type, 2018 - 2030 (USD Million)
TABLE 101 MEA Hemophilia Market, By Treatment Type, 2018 - 2030 (USD Million)
TABLE 102 MEA Hemophilia Market, By Therapy, 2018 - 2030 (USD Million)
TABLE 103 MEA Hemophilia Market, By Distribution Channel, 2018 - 2030 (USD Million)
TABLE 104 South Africa Hemophilia Market, By Type, 2018 - 2030 (USD Million)
TABLE 105 South Africa Hemophilia Market, By Treatment Type, 2018 - 2030 (USD Million)
TABLE 106 South Africa Hemophilia Market, By Therapy, 2018 - 2030 (USD Million)
TABLE 107 South Africa Hemophilia Market, By Distribution Channel, 2018 - 2030 (USD Million)
TABLE 108 Saudi Arabia Hemophilia Market, By Type, 2018 - 2030 (USD Million)
TABLE 109 Saudi Arabia Hemophilia Market, By Treatment Type, 2018 - 2030 (USD Million)
TABLE 110 Saudi Arabia Hemophilia Market, By Therapy, 2018 - 2030 (USD Million)
TABLE 111 Saudi Arabia Hemophilia Market, By Distribution Channel, 2018 - 2030 (USD Million)
TABLE 112 UAE Hemophilia Market, By Type, 2018 - 2030 (USD Million)
TABLE 113 UAE Hemophilia Market, By Treatment Type, 2018 - 2030 (USD Million)
TABLE 114 UAE Hemophilia Market, By Therapy, 2018 - 2030 (USD Million)
TABLE 115 UAE Hemophilia Market, By Distribution Channel, 2018 - 2030 (USD Million)
TABLE 116 KUWAIT Hemophilia Market, By Type, 2018 - 2030 (USD Million)
TABLE 117 KUWAIT Hemophilia Market, By Treatment Type, 2018 - 2030 (USD Million)
TABLE 118 KUWAIT Hemophilia Market, By Therapy, 2018 - 2030 (USD Million)
TABLE 119 KUWAIT Hemophilia Market, By Distribution Channel, 2018 - 2030 (USD Million)

★調査レポート[世界の血友病市場2023-2030：種類別（血友病A）、治療種類別（オンデマンド）、治療法別（遺伝子治療、モノクローナル抗体）、流通チャネル別、地域別] (コード：GRV23AUG060)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の血友病市場2023-2030：種類別（血友病A）、治療種類別（オンデマンド）、治療法別（遺伝子治療、モノクローナル抗体）、流通チャネル別、地域別]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の血液疾患市場（～2030年）： 種類別（血友病A、血友病B、フォンウィルブランド病、その他）、疾患別、治療種類別、流通チャネル別、地域別
  • 世界のがん免疫治療薬市場2023-2030：製品別（モノクローナル抗体、免疫調節剤）、用途別、流通チャネル別、エンドユーザー別、地域別
  • 世界の肝臓転移治療市場2023-2030：治療種類別（化学療法、免疫療法、標的療法）、原発性がん別（大腸がん、乳がん）、流通チャネル別、地域別
  • 世界の出血性疾患市場2023年-2032年：疾患種類別（血友病A、血友病B、フォンヴィレブランド病、その他）、治療種類別（因子補充療法、薬物療法）、流通チャネル別（病院薬局、ドラッグストア＆小売薬局、オンライン薬局）
  • 世界の結核治療薬市場2023-2030：疾患種類別（活動性結核、潜在性結核）、治療法別、投与経路別、剤形別、流通チャネル別、地域別
  • 世界の先進治療薬CDMO市場2023-2030：製品別（遺伝子治療、細胞治療、組織工学）、フェーズ別、疾患別、地域別
  • 世界の凍結療法市場2023-2030：治療種類別（凍結手術、チャンバー療法）、機器種類別（クライオチャンバー、クライオプローブ）、用途別（フィットネス、冷蔵保存）、エンドユーザー別、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆